rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Suven Pharmaceuticals Ltd. - Research Center
543064 SUVENPHAR Group (B) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Half yearly results in brief
(Rs crore)
Sep ' 20 Mar ' 20 Sep ' 19
Sales 475.62 363.47 470.32
Operating profit 210.60 157.02 227.95
Interest 6.47 14.38 7.43
Gross profit 210.23 152.86 228.41
EPS (Rs) 11.51 8.27 12.95
Half yearly  results in details
Sep ' 20 Mar ' 20 Sep ' 19
Other income 6.10 10.23 7.89
Stock adjustment 1.19 -24.31 13.26
Raw material 143.18 121.10 119.14
Power and fuel - - -
Employee expenses 38.37 37.09 32.31
Excise - - -
Admin and selling expenses - - -
Research and development expenses 6.89 - 8.03
Expenses capitalised - - -
Other expenses 75.38 72.57 69.63
Provisions made - - -
Depreciation 14.56 12.65 11.03
Taxation 49.10 34.97 52.54
Net profit / loss 146.56 105.24 164.84
Extra ordinary item - - -
Prior year adjustments - - -
Equity capital 12.73 12.73 12.73
Equity dividend rate - - -
Agg.of non-prom. shares (Lacs) - - -
Agg.of non promotoholding (%) - - -
OPM (%) 44.28 43.20 48.47
GPM (%) 43.64 40.91 47.76
NPM (%) 30.42 28.16 34.47

Mutual Fund Selector

Find the fund that is right for you

Buy? Sell? Hold?

Get the Latest Stock Tips
Close
Add Suven Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Suven Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close